Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for RxSight, Inc. (RXST : NSDQ)
 
 • Company Description   
RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

Number of Employees: 221

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.41 Daily Weekly Monthly
20 Day Moving Average: 65,930 shares
Shares Outstanding: 27.50 (millions)
Market Capitalization: $368.84 (millions)
Beta:
52 Week High: $19.67
52 Week Low: $8.80
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.79% 13.27%
12 Week 5.51% 11.08%
Year To Date 19.20% 38.95%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
100 COLUMBIA
-
ALISO VIEJO,CA 92656
USA
ph: 949-521-7830
fax: -
ir@rxsight.com http://www.rxsight.com
 
 • General Corporate Information   
Officers
Ron Kurtz - President; Chief Executive Officer and Director
J. Andy Corley - Chairman
Shelley Thunen - Chief Financial Officer
William Link - Director
Juliet Tammenoms Bakker - Director

Peer Information
RxSight, Inc. (ABMD)
RxSight, Inc. (DMDS)
RxSight, Inc. (CPWY.)
RxSight, Inc. (EQUR)
RxSight, Inc. (ECIA)
RxSight, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 78349D107
SIC: 3851
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 09/08/22
Share - Related Items
Shares Outstanding: 27.50
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $368.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.68 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.79 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.65
Price/Cash Flow: -
Price / Sales: 13.15
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -10.34%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 6.11%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -37.98
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 15.91
09/30/21 - 20.31
Quick Ratio
03/31/22 - -
12/31/21 - 15.19
09/30/21 - 19.28
Operating Margin
03/31/22 - -221.72
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -212.04
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -215.46
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 5.05
09/30/21 - 5.52
Inventory Turnover
03/31/22 - -
12/31/21 - 2.08
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.29
09/30/21 - 0.26
Debt-to-Capital
03/31/22 - -
12/31/21 - 22.34
09/30/21 - 20.80
 

Powered by Zacks Investment Research ©